Polycomb repressive complex 2 (PRC2) silences genes responsible for neurodegeneration

Nature Neuroscience

Volumn 19, Issue 10, 2016, Pages 1321-1330

  Von Schimmelmann, Melanie ^a   Feinberg, Philip A ^a   Sullivan, Josefa M ^a   Ku, Stacy M ^a   Badimon, Ana ^a   Duff, Mary Kaye ^a   Wang, Zichen ^a   Lachmann, Alexander ^a   Dewell, Scott ^b   Ma'ayan, Avi ^a   Han, Ming Hu ^a   Tarakhovsky, Alexander ^b   Schaefer, Anne ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLYCOMB REPRESSIVE COMPLEX 2; HISTONE LYSINE METHYLTRANSFERASE;

ADULT; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE INACTIVATION; GENE SILENCING; GENE TARGETING; MOUSE; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PURKINJE CELL; UPREGULATION; ANIMAL; CELL DEATH; DEFICIENCY; DEGENERATIVE DISEASE; FEMALE; GENETICS; KNOCKOUT MOUSE; MALE; METABOLISM; NERVE CELL;

ANIMALS; CELL DEATH; CELL SURVIVAL; DOWN-REGULATION; FEMALE; GENE SILENCING; HISTONE-LYSINE N-METHYLTRANSFERASE; MALE; MICE; MICE, KNOCKOUT; NERVE DEGENERATION; NEURODEGENERATIVE DISEASES; NEURONS; POLYCOMB REPRESSIVE COMPLEX 2;

EID: 84982124797     PISSN: 10976256     EISSN: 15461726     Source Type: Journal    
DOI: 10.1038/nn.4360     Document Type: Article

References (76)

1. Hobert, O. Regulation of terminal differentiation programs in the nervous system. Annu. Rev. Cell Dev. Biol. 27, 681-696 (2011).
2. Molyneaux, B.J., Arlotta, P., Menezes, J.R., & Macklis, J.D. Neuronal subtype specification in the cerebral cortex. Nat. Rev. Neurosci. 8, 427-437 (2007).
3. Deneris, E.S., & Hobert, O. Maintenance of postmitotic neuronal cell identity. Nat. Neurosci. 17, 899-907 (2014).
4. Corley, M., & Kroll, K.L. The roles and regulation of polycomb complexes in neural development. Cell Tissue Res. 359, 65-85 (2015).
5. Margueron, R., et al. Ezh1 and Ezh2 maintain repressive chromatin through different mechanisms. Mol. Cell 32, 503-518 (2008).
6. Margueron, R., & Reinberg, D. The Polycomb complex PRC2 and its mark in life. Nature 469, 343-349 (2011).
7. Laible, G., et al. Mammalian homologues of the Polycomb-group gene Enhancer of zeste mediate gene silencing in Drosophila heterochromatin and at S. cerevisiae telomeres. EMBO J. 16, 3219-3232 (1997).
8. Swigut, T., & Wysocka, J. H3K27 demethylases, at long last. Cell 131, 29-32 (2007).
9. He, X.B., et al. Vitamin C facilitates dopamine neuron differentiation in fetal midbrain through TET1-And JMJD3-dependent epigenetic control manner. Stem Cells 33, 1320-1332 (2015).
10. Palomer, E., Carretero, J., Benvegnù, S., Dotti, C.G., & Martin, M.G. Neuronal activity controls Bdnf expression via Polycomb de-repression and CREB/CBP/JMJD3 activation in mature neurons. Nat. Commun. 7, 11081 (2016).
11. Li, J., et al. EZH2-mediated H3K27 trimethylation mediates neurodegeneration in ataxia-Telangiectasia. Nat. Neurosci. 16, 1745-1753 (2013).
12. Södersten, E., et al. Dopamine signaling leads to loss of Polycomb repression and aberrant gene activation in experimental parkinsonism. PLoS Genet. 10, e1004574 (2014).
13. Seong, I.S., et al. Huntingtin facilitates polycomb repressive complex 2. Hum. Mol. Genet. 19, 573-583 (2010).
14. Dong, X., et al. The role of H3K4me3 in transcriptional regulation is altered in Huntington's disease. PLoS One 10, e0144398 (2015).
15. Biagioli, M., et al. Htt CAG repeat expansion confers pleiotropic gains of mutant huntingtin function in chromatin regulation. Hum. Mol. Genet. 24, 2442-2457 (2015).
16. Hoss, A.G., et al. MicroRNAs located in the Hox gene clusters are implicated in Huntington's disease pathogenesis. PLoS Genet. 10, e1004188 (2014).
17. Labadorf, A., et al. RNA sequence analysis of human Huntington disease brain reveals an extensive increase in inflammatory and developmental gene expressioN. PLoS One 10, e0143563 (2015).
18. Su, I.H., et al. Polycomb group protein ezh2 controls actin polymerization and cell signaling. Cell 121, 425-436 (2005).
19. Santos-Rosa, H., et al. Active genes are tri-methylated at K4 of histone H3. Nature 419, 407-411 (2002).
20. Voigt, P., Tee, W.W., & Reinberg, D. A double take on bivalent promoters. Genes Dev. 27, 1318-1338 (2013).
21. Bernstein, B.E., et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125, 315-326 (2006).
22. Ku, M., et al. Genomewide analysis of PRC1 and PRC2 occupancy identifies two classes of bivalent domains. PLoS Genet. 4, e1000242 (2008).
23. Heiman, M., et al. A translational profiling approach for the molecular characterization of CNS cell types. Cell 135, 738-748 (2008).
24. Lein, E.S., et al. Genome-wide atlas of gene expression in the adult mouse brain. Nature 445, 168-176 (2007).
25. Hersch, S.M., et al. Electron microscopic analysis of D1 and D2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with motor corticostriatal afferents. J. Neurosci. 15, 5222-5237 (1995).
26. Fridman, J.S., & Lowe, S.W. Control of apoptosis by p53. Oncogene 22, 9030-9040 (2003).
27. Kranenburg, O., van der Eb, A.J., & Zantema, A. Cyclin D1 is an essential mediator of apoptotic neuronal cell death. EMBO J. 15, 46-54 (1996).
28. Marathe, S., Liu, S., Brai, E., Kaczarowski, M., & Alberi, L. Notch signaling in response to excitotoxicity induces neurodegeneration via erroneous cell cycle reentry. Cell Death Differ. 22, 1775-1784 (2015).
29. Lovell, M.A., Xie, C., Xiong, S., & Markesbery, W.R. Wilms' tumor suppressor (WT1) is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer's disease. Brain Res. 983, 84-96 (2003).
30. Lu, X.H., et al. Targeting ATM ameliorates mutant Huntingtin toxicity in cell and animal models of Huntington's disease. Sci. Transl. Med. 6, 268ra178 (2014).
31. Illuzzi, J., Yerkes, S., Parekh-Olmedo, H., & Kmiec, E.B. DNA breakage and induction of DNA damage response proteins precede the appearance of visible mutant huntingtin aggregates. J. Neurosci. Res. 87, 733-747 (2009).
32. Anne, S.L., Saudou, F., & Humbert, S. Phosphorylation of huntingtin by cyclin-dependent kinase 5 is induced by DNA damage and regulates wild-Type and mutant huntingtin toxicity in neurons. J. Neurosci. 27, 7318-7328 (2007).
33. Turmaine, M., et al. Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease. Proc. Natl. Acad. Sci. USA 97, 8093-8097 (2000).
34. Orlando, V. Polycomb, epigenomes, and control of cell identity. Cell 112, 599-606 (2003).
35. Doyle, J.P., et al. Application of a translational profiling approach for the comparative analysis of CNS cell types. Cell 135, 749-762 (2008).
36. Savas, J.N., Toyama, B.H., Xu, T., Yates, J.R. III & Hetzer, M.W. Extremely long-lived nuclear pore proteins in the rat brain. Science 335, 942 (2012).
37. Duerre, J.A., & Lee, C.T. In vivo methylation and turnover of rat brain histones. J. Neurochem. 23, 541-547 (1974).
38. Culhane, J.C., & Cole, P.A. LSD1 and the chemistry of histone demethylation. Curr. Opin. Chem. Biol. 11, 561-568 (2007).
39. Dobenecker, M.W., et al. Coupling of T cell receptor specificity to natural killer T cell development by bivalent histone H3 methylation. J. Exp. Med. 212, 297-306 (2015).
40. Mohn, F., et al. Lineage-specific polycomb targets and de novo DNA methylation define restriction and potential of neuronal progenitors. Mol. Cell 30, 755-766 (2008).
41. Barski, A., et al. High-resolution profiling of histone methylations in the human genome. Cell 129, 823-837 (2007).
42. Wachter, E., et al. Synthetic CpG islands reveal DNA sequence determinants of chromatin structure. eLife 3, e03397 (2014).
43. Mendenhall, E.M., et al. GC-rich sequence elements recruit PRC2 in mammalian ES cells. PLoS Genet. 6, e1001244 (2010).
44. Kaneko, S., Son, J., Bonasio, R., Shen, S.S., & Reinberg, D. Nascent RNA interaction keeps PRC2 activity poised and in check. Genes Dev. 28, 1983-1988 (2014).
45. Jadhav, U., et al. Acquired tissue-specific promoter bivalency is a basis for PRC2 necessity in adult cells. Cell 165, 1389-1400 (2016).
46. Langfelder, P., et al. Integrated genomics and proteomics define huntingtin CAG length-dependent networks in mice. Nat. Neurosci. 19, 623-633 (2016).
47. Vashishtha, M., et al. Targeting H3K4 trimethylation in Huntington disease. Proc. Natl. Acad. Sci. USA 110, E3027-E3036 (2013).
48. Klapstein, G.J., et al. Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice. J. Neurophysiol. 86, 2667-2677 (2001).
49. Menalled, L.B., & Chesselet, M.F. Mouse models of Huntington's disease. Trends Pharmacol. Sci. 23, 32-39 (2002).
50. Reynolds, J.P., et al. Transcriptional response of Polycomb group genes to status epilepticus in mice is modified by prior exposure to epileptic preconditioning. Front. Neurol. 6, 46 (2015).
51. Casanova, E., et al. A CamKIIalpha iCre BAC allows brain-specific gene inactivation. Genesis 31, 37-42 (2001).
52. Schaefer, A., et al. Cerebellar neurodegeneration in the absence of microRNAs. J. Exp. Med. 204, 1553-1558 (2007).
53. Zhang, X.M., et al. Highly restricted expression of Cre recombinase in cerebellar Purkinje cells. Genesis 40, 45-51 (2004).
54. Ezhkova, E., et al. EZH1 and EZH2 cogovern histone H3K27 trimethylation and are essential for hair follicle homeostasis and wound repair. Genes Dev. 25, 485-498 (2011).
55. Maze, I., et al. G9a influences neuronal subtype specification in striatum. Nat. Neurosci. 17, 533-539 (2014).
56. Maze, I., et al. Essential role of the histone methyltransferase G9a in cocaine-induced plasticity. Science 327, 213-216 (2010).
57. Kriaucionis, S., & Heintz, N. The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 324, 929-930 (2009).
58. Gao, Z., et al. An AUTS2-Polycomb complex activates gene expression in the CNS. Nature 516, 349-354 (2014).
59. Mullen, R.J., Buck, C.R., & Smith, A.M. NeuN, a neuronal specific nuclear protein in vertebrates. Development 116, 201-211 (1992).
60. Goodarzi, H., Elemento, O., & Tavazoie, S. Revealing global regulatory perturbations across human cancers. Mol. Cell 36, 900-911 (2009).
61. Tan, C.L., et al. MicroRNA-128 governs neuronal excitability and motor behavior in mice. Science 342, 1254-1258 (2013).
62. Schaefer, A., et al. Control of cognition and adaptive behavior by the GLP/G9a epigenetic suppressor complex. Neuron 64, 678-691 (2009).
63. Cartharius, K., et al. MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 21, 2933-2942 (2005).
64. Kwon, A.T., Arenillas, D.J., Worsley Hunt, R., & Wasserman, W.W. oPOSSUM-3: advanced analysis of regulatory motif over-representation across genes or ChIP-Seq datasets. G3 (Bethesda) 2, 987-1002 (2012).
65. Sandelin, A., Alkema, W., Engström, P., Wasserman, W.W., & Lenhard, B. JASPAR: an open-Access database for eukaryotic transcription factor binding profiles. Nucleic Acids Res. 32, D91-D94 (2004).
66. Dermitzakis, E.T., & Clark, A.G. Evolution of transcription factor binding sites in mammalian gene regulatory regions: conservation and turnover. Mol. Biol. Evol. 19, 1114-1121 (2002).
67. Lenhard, B., et al. Identification of conserved regulatory elements by comparative genome analysis. J. Biol. 2, 13 (2003).
68. Chen, E.Y., et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics 14, 128 (2013).
69. Kuleshov, M.V., et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 44 W1: W90-W97 (2016).
70. Tan, C.M., Chen, E.Y., Dannenfelser, R., Clark, N.R., & Ma'ayan, A. Network2Canvas: network visualization on a canvas with enrichment analysis. Bioinformatics 29, 1872-1878 (2013).
71. Lachmann, A., et al. ChEA: transcription factor regulation inferred from integrating genome-wide ChIP-X experiments. Bioinformatics 26, 2438-2444 (2010).
72. ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57-74 (2012).
73. Sullivan, J.M., et al. Autism-like syndrome is induced by pharmacological suppression of BET proteins in young mice. J. Exp. Med. 212, 1771-1781 (2015).
74. Crawley, J.N. What's Wrong with My Mouse? Behavioral Phenotyping of Transgenic and Knockout Mice 2nd edn. (Wiley-Interscience, 2007).
75. Lobo, M.K., et al. Cell type-specific loss of BDNF signaling mimics optogenetic control of cocaine reward. Science 330, 385-390 (2010).
76. Wallace, D.L., et al. CREB regulation of nucleus accumbens excitability mediates social isolation-induced behavioral deficits. Nat. Neurosci. 12, 200-209 (2009).